http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7855635eb77e935141bffddce1d20d18
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Tamamura |
| name | Hirokazu Tamamura |
| given-name | Hirokazu |
| organization-name | Graduate School of Pharmaceutical Science, Kyoto University, Kyoto, Japan Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan; Graduate School of Biomedical Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University, Chiyoda‐Ku Tokyo 101‐0062 Japan Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo, Japan Department of Molecular Virology, Tokyo Medical and Dental University (TMDU), Tokyo 113-8519, Japan Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU) Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan, School of Biomedical Science, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo 101-0062, Japan. Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan From the Division of Hematology/Oncology, Department of Medicine, Freiburg University Hospital, Freiburg, Germany; the Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan; and the Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, CA. From the Department of Oncology and Surgical Sciences, Oncology Section, University of Padua, Italy; Istituto Nazionale per la Ricerca sul Cancro-IST, Genua, Italy; Department of Clinical and Experimental Medicine, Clinical Immunology Branch, University of Padua, Italy; Graduate School of Pharmaceutical Sciences, Kyoto University, Japan; Azienda Ospedaliera Padova, Padua, Italy; and Venetian Institute for Molecular Medicine, Padua, Italy. Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501,6 Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan, and Minase Research Institute, Ono Pharmaceutical Co. Ltd., Mishima-gun, Osaka 618-8585, Japan Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan and Fujisawa Pharmaceutical Co., Ltd., Kashima, Yodogawa-ku, Osaka 532-8514, Japan Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo 101-0062, Japan, and AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo 162-8640, Japan Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan; Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku Tokyo 101-0062, Japan; Medical College of Georgia, Augusta, Georgia 30912; James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky 40202; St. Marianna University, School of Medicine, Miyamae-ku, Kawasaki 216-8511, Japan; and Tokyo Medical and Dental University, School of Medicine, Bunkyo-ku,... Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501,2 Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan, and Minase Research Institute, Ono Pharmaceutical Co. Ltd., Mishima-gun, Osaka, 618-8585, Japan Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo 101-0062, Japan Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. Electronic address: tamamura.mr@tmd.ac.jp. Laboratories of Medicinal Chemistry and of Cellular Carcinogenesis and Tumor Promotion, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan, Fujisawa Pharmaceutical Co., Ltd., Kashima, Yodogawa-ku, Osaka 532-8514, Japan, and Minase Research Institute, Ono Pharmaceutical Co. Ltd., Mishima-gun, Osaka 618-8585, Japan Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan, and Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan, and AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo 101-0062, Japan Graduate School of Pharmacological Sciences Kyoto University Kyoto Kyoto 606‐8501 Japan Faculty of Pharmaceutical Sciences, Kyoto University, Sakyo, Kyoto 606, Japan Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo 101-0062, Japan, Graduate School of Engineering, Kyoto University, Nishikyo-ku, Kyoto 615-8510, Japan, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan, School of Medicine, St. Marianna University, Miyamae-ku, Kawasaki 216-8511, Japan, and AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo 162-8640, Japan Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan, Department of Pathology, Medical College of Georgia, Georgia 30912, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku Tokyo 101-0062, Japan, St. Marianna University, School of Medicine, Miyamae-ku, Kawasaki 216-8511, Japan, and James Graham Brown Cancer Center, University of Louisville, Kentucky 40202 Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University Chiyoda‐ku Tokyo 101‐0062 Japan Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, and Laboratory of Cellular Carcinogenesis & Tumor Promotion, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University 2‐3‐10 Kandasurugadai Chiyoda‐ku Tokyo 101‐0062 Japan From the *Department of Microbiology, Tokyo Medical and Dental University School of Medicine, Bunkyo-ku, Tokyo 113, Japan; ‡Shionogi Institute for Medical Science, 2-5-1 Mishima, Settsu, Osaka 566, Japan; §Department of Immunology, Research Institute, Osaka Medical Center for Maternal and Child Health, 840 Murodo-cho, Izumi, Osaka 590-02, Japan; and ‖Faculty of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606, Japan; ¶SEIKAGAKU Corp., Chyuo-ku, Tokyo 103, Japan; **Department of Medicine III, Osaka University Medical School, 2-2 Yamada-oka, Suita, Osaka 565, Japan Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan; Department of Internal Medicine II, Kumamoto University School of Medicine, Kumamoto 860-8556, Japan; Yokohama Laboratory, SC BioSciences Corporation, Hodogaya-ku, Yokohama 240-0005, Japan; and Experimental Retrovirology Section, Medicine Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 2Department of Bioorganic Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan, and Fujisawa Pharmaceutical Co., Ltd., Kashima, Yodogawa-ku, Osaka 532-8514, Japan Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan, Department of Pathology and Immunotherapy Center, Medical College of Georgia, Augusta, Georgia 30912, and Graduate School of Pharmaceutical Sciences, The University of Tokushima, Tokushima 770-8505, Japan Institute of Biomaterials and Bioengineering; Tokyo Medical and Dental University; Tokyo 101-0062; Japan Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan; Graduate School of Biomedical Science, Tokyo Medical and Dental University, 1-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan, Medical College of Georgia, Augusta, Georgia 30912, St. Marianna University, School of Medicine, Miyamae-ku, Kawasaki 216-8511, Japan, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky 40202, and Tokyo Medical and Dental University, School of Medicine, Bunkyo-ku, Tokyo 113-8519, Japan Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan 5Department of Bioorganic Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan; and Institute of Biomaterials & Bioengineering Tokyo Medical & Dental University 2-3-10 Kandasurugadai Chiyoda-ku Tokyo 101-0062 Japan Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan, Minase Research Institute, Ono Pharmaceutical Co. Ltd., Mishima-gun, Osaka, 618-8585, Japan, and Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd., Kohoku-ku, Yokohama, 222-0002, Japan Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer InstituteFrederick, National Institutes of Health, Building 376, Room 104, Frederick, Maryland 21702, and Laboratory of Cellular Carcinogenesis & Tumor Promotion, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 3A01, Bethesda, Maryland 20892 Department of Pharmaceutical Manufacturing Graduate School of Pharmaceutical Science, Kyoto University Kyoto Kyoto 606‐8502 Japan Institute of Biomaterials and Bioengineering; Tokyo Medical and Dental University; Chiyoda-ku; Japan |
Incoming Links
Total number of triples: 250.